索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 期刊目录
  • 乌尔里希的期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • 普罗奎斯特传票
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Autoimmune Derangement in a Patient with Simultaneous Diagnoses of Primary Anti phospholipid Syndrome, Thrombotic Thrombocytopenic Purpura and Heparin Induced Thrombocytopenia

Komal Khiani, Yair Keilson, Philip Rubin, William Solomon, Yevgenia Margulis, Yiwu Huang and Yiqing Xu

Primary antiphospholipid syndrome (APS), thrombotic thrombocytopenic purpura (TTP) and heparin induced thrombocytopenia (HIT) are all hypercoagulable conditions characterized by thrombocytopenia and high risks of thrombosis. A severe form of APS, namely catastrophic antiphospholipid syndrome (CAPS), further shares features with TTP by the presence of microangiopathic hemolytic anemia characterized by schistocytes on the blood smear. CAPS and TTP may be co-existing and an underlying autoimmune association was postulated. Here we report a patient who presented with initial symptoms of APS, who then simultaneously developed TTP and HIT after being exposed to Clopidogrel and Heparin. Our case suggests that the autoimmune deregulation in APS predisposes the patient to other immune related conditions.